Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

PhII ICb With/Without Erbitux in MBC Pts

ClinicalTrials.gov ID: NCT00248287

Public ClinicalTrials.gov record NCT00248287. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 28, 2026, 3:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase II Study of Weekly Irinotecan/Carboplatin (ICb) With or Without Cetuximab (Erbitux) in Patients With Metastatic Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the objective response rates produced by irinotecan and carboplatin therapy with or without Erbitux in patients with Metastatic Breast Cancer.

Study identification

NCT ID
NCT00248287
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
154 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 27, 2005
Primary completion
Nov 30, 2025
Completion
Nov 30, 2026
Last update posted
Jan 28, 2025

2005 – 2026

United States locations

U.S. sites
59
U.S. states
22
U.S. cities
56
Facility City State ZIP Site status
Birmingham Hematology and Oncology Birmingham Alabama 35205 —
Hematology Oncology Asscociates Phoenix Arizona 85012 —
Northern AZ Hematology & Oncology Assoc Sedona Arizona 86336 —
Rocky Mountain Cancer Center-Rose Denver Colorado 80220 —
Northwestern Connecticut Oncology Hematology Associates Torrington Connecticut 06790 —
Melbourne Internal Medicine Associates Melbourne Florida 32901 —
Florida Cancer Institute New Port Richey Florida 34655 —
Ocala Oncology Center Ocala Florida 34474 —
Cancer Centers of Florida, P.A. Ocoee Florida 34761 —
Hematology Oncology Associates of IL Chicago Illinois 60611 —
Central Indiana Cancer Center Indianapolis Indiana 46227 —
Kansas City Cancer-Southwest Overland Park Kansas 66210 —
Maryland Oncology Hematology, P.A. Columbia Maryland 21044 —
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404 —
Missouri Cancer Associates Columbia Missouri 65201 —
Arch Medical Services, Inc St Louis Missouri 63141 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109 —
NH Oncology-Hematology PA Hooksett New Hampshire 03106 —
Hematology-Oncology Associates of NNJ, P.A. Morristown New Jersey 07960 —
Summit Medical Group Summit New Jersey 07901 —
New York Oncology Hematology, P.C. Albany New York 12208 —
New York Oncology Hematology, PC Rexford New York 12148 —
Interlakes Oncology Hematology, PC Rochester New York 14623 —
Raleigh Hematology Oncology Clinic Cary North Carolina 27511 —
Greater Dayton Cancer Center Kettering Ohio 45409 —
Willamette Valley Cancer Center Eugene Oregon 97401 —
Cancer Center of the Carolinas, Seneca Seneca South Carolina 29672 —
Texas Cancer Center-Abilene(South) Abilene Texas 79606 —
Texas Cancer Center Arlington Texas 76014 —
Texas Oncology Cancer Center Austin Texas 78731 —
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702 —
Texas Oncology, P.A. - Bedford Bedford Texas 76022 —
Texas Cancer Center at Medical City Dallas Texas 75230 —
Texas Oncology, P.A. Dallas Texas 75231 —
The Texas Cancer Center Dallas Texas 75237 —
Texas Oncology, P.A. Dallas Texas 75246 —
Texas Oncology Center - Denton Denton Texas 76210 —
El Paso Cancer Treatment Ctr El Paso Texas 79915 —
Texas Oncology, P.A. Fort Worth Texas 76104 —
San Antonio Tumor & Blood Clinic Fredericksburg Texas 78624 —
Texas Oncology, P.A. Houston Texas 77024 —
Longview Cancer Center Longview Texas 75601 —
South Texas Cancer Center-McAllen McAllen Texas 78503 —
Texas Cancer Center of Mesquite Mesquite Texas 75150 —
Allison Cancer Center Midland Texas 79701 —
HOAST - New Braunfels New Braunfels Texas 78131 —
West Texas Cancer Center Odessa Texas 79761 —
Paris Regional Cancer Center Paris Texas 75460 —
Texas Cancer Center-Sherman Sherman Texas 75090 —
Texas Oncology Cancer Center-Sugar Land Sugar Land Texas 77479 —
Tyler Cancer Center Tyler Texas 75702 —
Waco Cancer Care and Research Center Waco Texas 76712 —
Virginia Oncology Associates Norfolk Virginia 23505 —
Onc and Hem Associates of SW VA, Inc. Salem Virginia 24153 —
Puget Sound Cancer Center-Emonds Edmonds Washington 98026 —
Puget Sound Cancer Center-Seattle Seattle Washington 98133 —
Cancer Care Northwest-South Spokane Washington 99202 —
Northwest Cancer Specialists-Vancouver Vancouver Washington 98684 —
Yakima Valley Mem Hosp/North Star Lodge Yakima Washington 98902 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00248287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2025 · Synced Sep 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00248287 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →